Aaron Schuchart serves as Executive at Aeglea BioTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Aaron Schuchart has executed 11 insider transactions totaling $71.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 1, 2024 involved receiving (via award) 1,000 shares valued at $2.8K.
Aaron Schuchart currently holds 6,679 shares of Aeglea BioTherapeutics, Inc. (AGLE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron Schuchart has been a net seller of AGLE stock. They have purchased $14.8K and sold $57.0K worth of shares.
Aaron Schuchart's most recent insider trade was on Apr 1, 2024, when they sold 1,000 shares at $2.84 per share.
Get notified when new Form 4 filings are submitted
| $3.01 |
| Discretionary |
| Feb 1, 2023 | (LUMO) | $3.5K | Award | 1,000 | $3.52 | Discretionary |
| Feb 1, 2023 | (LUMO) | $366 | Payment | 104 | $3.52 | Discretionary |
| Feb 1, 2022 | (LUMO) | $521 | Payment | 52 | $10.02 | Discretionary |
| Feb 1, 2022 | (LUMO) | $10.0K | Award | 1,000 | $10.02 | Discretionary |
| Aug 12, 2021 | (LUMO) | $12.6K | Purchase | 1,700 | $7.42 | Discretionary |
| Aug 11, 2021 | (LUMO) | $2.2K | Purchase | 300 | $7.35 | Discretionary |
| Sep 27, 2018 | AGLE | $56.0K | Sale | 5,900 | $9.50 | Discretionary |
| Sep 27, 2018 | AGLE | $955 | Sale | 100 | $9.55 | Discretionary |
| Aug 17, 2018 | AGLE | $29.8K | Option Exercise | 8,500 | $3.50 | Discretionary |